Atlas Trials

A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

Clinical trial NCT01860989 · COMPLETED

Trial details

NCT number
NCT01860989
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cure Rate
Start date
2013-07-01
Primary completion
2014-08-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.